DE60002185D1 - Transplantation von hämatopoietischen zellen - Google Patents

Transplantation von hämatopoietischen zellen

Info

Publication number
DE60002185D1
DE60002185D1 DE60002185T DE60002185T DE60002185D1 DE 60002185 D1 DE60002185 D1 DE 60002185D1 DE 60002185 T DE60002185 T DE 60002185T DE 60002185 T DE60002185 T DE 60002185T DE 60002185 D1 DE60002185 D1 DE 60002185D1
Authority
DE
Germany
Prior art keywords
transplantation
hematopoietic cells
disease
treatment
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60002185T
Other languages
English (en)
Other versions
DE60002185T2 (de
Inventor
Jack Price
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reneuron Ltd
Original Assignee
Reneuron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Ltd filed Critical Reneuron Ltd
Application granted granted Critical
Publication of DE60002185D1 publication Critical patent/DE60002185D1/de
Publication of DE60002185T2 publication Critical patent/DE60002185T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60002185T 1999-02-24 2000-02-23 Transplantation von hämatopoietischen zellen Expired - Lifetime DE60002185T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904281.4A GB9904281D0 (en) 1999-02-24 1999-02-24 Transplantation
PCT/GB2000/000636 WO2000050568A2 (en) 1999-02-24 2000-02-23 Transplantation of haematopoietic cells

Publications (2)

Publication Number Publication Date
DE60002185D1 true DE60002185D1 (de) 2003-05-22
DE60002185T2 DE60002185T2 (de) 2003-12-18

Family

ID=10848438

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60002185T Expired - Lifetime DE60002185T2 (de) 1999-02-24 2000-02-23 Transplantation von hämatopoietischen zellen

Country Status (20)

Country Link
EP (1) EP1161521B1 (de)
JP (1) JP4716575B2 (de)
KR (1) KR20020000216A (de)
CN (1) CN1636053A (de)
AT (1) ATE237680T1 (de)
AU (1) AU762763B2 (de)
CA (1) CA2361401A1 (de)
CZ (1) CZ20012651A3 (de)
DE (1) DE60002185T2 (de)
DK (1) DK1161521T3 (de)
ES (1) ES2193938T3 (de)
GB (1) GB9904281D0 (de)
HK (1) HK1041284B (de)
HU (1) HUP0105168A3 (de)
NO (1) NO20014091D0 (de)
PL (1) PL350297A1 (de)
PT (1) PT1161521E (de)
RU (1) RU2216336C2 (de)
SK (1) SK11232001A3 (de)
WO (1) WO2000050568A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518606D0 (en) 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
US8017112B2 (en) 1999-05-14 2011-09-13 Henry Ford Health System Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
CA2373808C (en) * 1999-05-14 2011-04-19 Henry Ford Health System Bone marrow transplantation for treatment of central nervous system damage
US7687505B2 (en) * 2002-01-14 2010-03-30 Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
US20060051860A1 (en) * 2002-11-15 2006-03-09 Kyushu Tlo Company, Limited Method of organ regeneration
ATE373081T1 (de) 2004-09-30 2007-09-15 Reneuron Ltd Zelllinie
RU2283119C1 (ru) * 2005-03-29 2006-09-10 Андрей Степанович БРЮХОВЕЦКИЙ Препарат аутологичных гемопоэтических стволовых клеток, способ его получения, криоконсервации и использования для лечения травматической болезни центральной нервной системы
US7569545B2 (en) * 2005-05-20 2009-08-04 Academia Sinica Methods of increasing neurotrophic factor expression
AU2007230902B2 (en) 2006-03-24 2013-03-14 Children's Medical Center Corporation Method to modulate hematopoietic stem cell growth
CA2666972C (en) 2006-10-20 2015-12-29 Children's Medical Center Corporation Method to enhance tissue regeneration
EP2326330B1 (de) 2008-09-16 2015-01-07 University Of Central Florida Research Foundation, Inc. Zusammensetzungen zur behandlung oder verzögerung des beginns von haarverlust
US9056085B2 (en) 2009-02-03 2015-06-16 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
WO2010091052A2 (en) 2009-02-03 2010-08-12 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
GB0902034D0 (en) 2009-02-06 2009-03-11 Reneuron Ltd Method
WO2012145723A1 (en) * 2011-04-20 2012-10-26 The Regents Of The University Of California Method for combined conditioning and chemoselection in a single cycle
EP3381456A1 (de) 2011-12-02 2018-10-03 Fate Therapeutics, Inc. Verbesserte verfahren zur behandlung von ischämie
CA2857640C (en) 2011-12-02 2021-11-16 Fate Therapeutics, Inc. Enhanced stem cell composition
WO2014150602A1 (en) 2013-03-15 2014-09-25 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
RU2647429C1 (ru) * 2017-02-06 2018-03-15 Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) Биомедицинский клеточный препарат
RU2720002C1 (ru) * 2018-12-28 2020-04-23 Андрей Степанович БРЮХОВЕЦКИЙ Биомедицинский клеточный продукт для лечения нервных болезней и психических расстройств, способ его получения и его применение
CN114934072B (zh) * 2022-05-18 2023-10-20 华中科技大学同济医学院附属协和医院 一种人心脏瓣膜间质细胞系的永生化构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
AU680406B2 (en) * 1992-03-04 1997-07-31 Systemix, Inc. Culturing of hematopoietic stem cells and their genetic engineering
EE03509B2 (et) * 1995-06-27 2015-02-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks
GB9518606D0 (en) * 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
AU740709B2 (en) * 1996-08-19 2001-11-15 University Of Massachusetts Embryonic or stem-like cell lines produced by cross species nuclear transplanta tion

Also Published As

Publication number Publication date
CZ20012651A3 (cs) 2002-01-16
PT1161521E (pt) 2003-08-29
KR20020000216A (ko) 2002-01-05
WO2000050568A3 (en) 2000-12-07
SK11232001A3 (sk) 2002-01-07
DK1161521T3 (da) 2003-06-16
PL350297A1 (en) 2002-12-02
HUP0105168A3 (en) 2003-12-29
DE60002185T2 (de) 2003-12-18
NO20014091L (no) 2001-08-23
EP1161521A2 (de) 2001-12-12
HK1041284B (zh) 2003-10-03
HUP0105168A2 (hu) 2002-05-29
AU762763B2 (en) 2003-07-03
HK1041284A1 (en) 2002-07-05
NO20014091D0 (no) 2001-08-23
ATE237680T1 (de) 2003-05-15
AU2682100A (en) 2000-09-14
GB9904281D0 (en) 1999-04-21
CN1636053A (zh) 2005-07-06
WO2000050568A2 (en) 2000-08-31
JP2002537406A (ja) 2002-11-05
CA2361401A1 (en) 2000-08-31
ES2193938T3 (es) 2003-11-16
EP1161521B1 (de) 2003-04-16
RU2216336C2 (ru) 2003-11-20
JP4716575B2 (ja) 2011-07-06

Similar Documents

Publication Publication Date Title
DE60002185D1 (de) Transplantation von hämatopoietischen zellen
ATE426661T1 (de) Somatische pluripotente zellen
NO20004803L (no) Smilagening og anzurogenin for behandling av Alzheimers sykdom
GB0400167D0 (en) Dopaminergic neurons and proliferation-competent orecursor cells for treating parkinson's disease
GT199600026A (es) Isotiazolonas
NZ509729A (en) Agents with an antidepressive effect
ATE476155T1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
DE59603216D1 (de) Esterquats und ihre Verwendung zur Herstellung von oberflächenaktiven Mitteln, insbesondere zur Haar- und Körperpflege
BR0014169A (pt) Lentes de adição progressiva
GB2407821A (en) Generation of neural stem cells from undifferentiated human embryonic stem cells
WO2003039454A8 (en) Beta-secretase inhibitors and methods of use
WO2003102016A3 (en) Amyloid peptide inactivating enzyme to treat alzheimer's disease
WO1998013488A3 (en) Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease
HK1075673A1 (en) Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease
HK1080408B (zh) 溴莫尼定在治療痴呆和帕金森病中的用途
NO995440D0 (no) Ny klasse fotoaktive benzoporfyrinderivat-forbindelser
BR0013221A (pt) Chá preto de folha
ATE464048T1 (de) Behandlung von alzheimer-krankheit und verwandten zuständen
DE60043888D1 (de) Oberfläche für zellkultur
DE50010234D1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
CA95616S (en) Tanned hide
DE29704643U1 (de) Aussparungskörper für die Herstellung von Köcherfundamenten
RU2002116475A (ru) Способ лечения паркинсонизма и болезни паркинсона
AU307303S (en) Ride on zebra
CA102501S (en) Light adjustor for computer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition